000 | 01735 a2200469 4500 | ||
---|---|---|---|
005 | 20250513132435.0 | ||
264 | 0 | _c19980107 | |
008 | 199801s 0 0 eng d | ||
022 | _a0009-2797 | ||
024 | 7 |
_a10.1016/s0009-2797(97)00071-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLi, A P | |
245 | 0 | 0 |
_aPrimary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin. _h[electronic resource] |
260 |
_bChemico-biological interactions _cNov 1997 |
||
300 |
_a17-30 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_aAntibiotics, Antitubercular _xmetabolism |
650 | 0 | 4 |
_aAntitubercular Agents _xmetabolism |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xbiosynthesis |
650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
650 | 0 | 4 |
_aEnzyme Induction _xdrug effects |
650 | 0 | 4 |
_aGlucuronates _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydroxylation |
650 | 0 | 4 |
_aIsoenzymes _xbiosynthesis |
650 | 0 | 4 |
_aLiver _xcytology |
650 | 0 | 4 |
_aRifabutin _xmetabolism |
650 | 0 | 4 |
_aRifampin _xanalogs & derivatives |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aTestosterone _xmetabolism |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aZidovudine _xmetabolism |
700 | 1 | _aReith, M K | |
700 | 1 | _aRasmussen, A | |
700 | 1 | _aGorski, J C | |
700 | 1 | _aHall, S D | |
700 | 1 | _aXu, L | |
700 | 1 | _aKaminski, D L | |
700 | 1 | _aCheng, L K | |
773 | 0 |
_tChemico-biological interactions _gvol. 107 _gno. 1-2 _gp. 17-30 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0009-2797(97)00071-9 _zAvailable from publisher's website |
999 |
_c9372583 _d9372583 |